HIGHLIGHTS
- who: Wei Liu and collaborators from the Wuhan University of Technology, China have published the research work: Application status and future prospects of the PDX model in lung cancer, in the Journal: (JOURNAL)
- how: The results showed that patients had different sensitivity to the three regimens.
SUMMARY
Cell lines lose critical properties after long-term in_vitro culture. In response to the need for effective anti-cancer drugs, the National Cancer Institute (NCI, MD, USA) recommended the PDX models and discontinued the NCI-60 cancer cell line approach. The EurOPDX Consortium, containing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.